• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • POLITICS
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • LAW & HUMAN RIGHTS
    • Oil & Gas/Mineral Resources
    • PRESS FREEDOM/JOURNALISM/PR
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • Abramowitz announces $500m solar financing for Nigerian universities
  • Katsina unveils guidelines for state-funded family planning commodities
  • FCTA to build more modern bus, taxi terminals in Abuja
  • Lagos launches access to market initiative for MSMEs
  • LASCAFAN Intensifies drive to attract youth into fish farming
  • De Renaissance Patriots seeks lasting economic benefits for Lagos indigenes from Dangote Refinery, other major investments
  • Kano suspends SMC malaria programme for probe
  • Osun denies ₦11bn looting allegation, accuses EFCC of political witch-hunt
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    LASCAFAN Intensifies drive to attract youth into fish farming

    August 6, 2026

    Santuscom foods begins UK exports

    August 6, 2026

    Yaba shop owners lament losses after LAWMA seals premises

    August 6, 2026

    El Niño may push 6m more into hunger across West, Central Africa – WFP

    August 5, 2026

    Ghana cocoa output set to fall 16% in 2026/27 season, raising global price fears

    August 5, 2026
  • Sci & Tech

    Abramowitz announces $500m solar financing for Nigerian universities

    August 6, 2026

    Stakeholders to assess GSM’s 25 year impact

    August 6, 2026

    Precision farming can boost Nigeria’s food output – Expert

    August 5, 2026

    NCC hands over digital facilities to Enugu govt

    August 5, 2026

    FG directs MDAs to comply with data protection act

    August 4, 2026
  • Health

    Katsina unveils guidelines for state-funded family planning commodities

    August 6, 2026

    Kano suspends SMC malaria programme for probe

    August 6, 2026

    FG rallies support for Miss Nigeria at Miss World

    August 6, 2026

    Fathers urge support for exclusive breastfeeding

    August 6, 2026

    Apapa general hospital reaffirms commitment to maternal, child healthcare

    August 6, 2026
  • Environment

    FCTA to build more modern bus, taxi terminals in Abuja

    August 6, 2026

    Lagos launches access to market initiative for MSMEs

    August 6, 2026

    SHINE Collab calls for stronger legal protection as Africa’s mineral boom reshapes communities

    August 6, 2026

    FCT water board restores supply to Wuse, Wuye, Maitama

    August 6, 2026

    SURWASH trains officers on strategic communication, storytelling

    August 6, 2026
  • Hausa News

    UNA signs MoU to launch air Bissau in Guinea-Bissau

    June 15, 2026

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025

    [BIDIYO] Yadda na lashe gasa ta duniya a fannin Ingilishi – Rukayya ‘yar shekara 17

    August 6, 2025

    A Saka Baki, A Sasanta Saɓani Tsakanin ‘Yanjarida Da Liman, Daga Muhammad Sajo

    May 21, 2025
  • More
    1. Business/Banking & Finance
    2. POLITICS
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. LAW & HUMAN RIGHTS
    24. Oil & Gas/Mineral Resources
    25. PRESS FREEDOM/JOURNALISM/PR
    26. General News
    27. Presidency
    Featured
    Recent

    Abramowitz announces $500m solar financing for Nigerian universities

    August 6, 2026

    Katsina unveils guidelines for state-funded family planning commodities

    August 6, 2026

    FCTA to build more modern bus, taxi terminals in Abuja

    August 6, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    Abramowitz announces $500m solar financing for Nigerian universities

    August 6, 2026

    Katsina unveils guidelines for state-funded family planning commodities

    August 6, 2026

    FCTA to build more modern bus, taxi terminals in Abuja

    August 6, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»Health & Healthy Living»[EXPLAINER] List of drugs linked to dementia, By Nicole Rowe
Health & Healthy Living

[EXPLAINER] List of drugs linked to dementia, By Nicole Rowe

EditorBy EditorFebruary 16, 2026Updated:February 16, 2026No Comments5 Mins Read
Dementia
Share
Facebook Twitter LinkedIn Pinterest Email

Key takeaways: Certain medications are linked to an increased risk of dementia. But that doesn’t mean they necessarily cause dementia.

  • Medications that have been associated with increased risk of dementia include overactive bladder medications, pain medications, heartburn medications, and certain anxiety medications.
  • The risk of dementia with these medications increases when you take higher doses over longer periods of time.
  • Dementia is a growing concern among many aging people in the U.S., especially Alzheimer’s disease. And since treatment options for dementia are limited, prevention is key. 
  • Dementia risk is tied to common things like diabetes, high blood pressure, and physical inactivity. But some common medications are associated with dementia risk, too. Here are four common drug classes linked to dementia, and what the research says about your risk.

1. Anticholinergic medications

  • Anticholinergic medications block a chemical called acetylcholine in the body. Acetylcholine works like a chemical messenger in the nervous system. It affects learning, memory, movement, and even emotions. And people with Alzheimer’s disease often have low levels of acetylcholine in their bodies. 
  • In one large study of almost 300,000 people, the risk of dementia was significantly higher in those who had taken the highest cumulative doses of strong anticholinergic medications.  Another large study in adults over 65 years old confirmed these findings. Other studies have shown that the use of an anticholinergic medication can worsen dementia in people who are already experiencing cognitive decline.  
  • But not all studies have such clear-cut findings. For example, even though diphenhydramine (Benadryl) has strong anticholinergic activity, current research is unclear on whether diphenhydramine increases the risk of dementia. 
  • Some common anticholinergic medications include antihistamines, tricyclic antidepressants, medications for irritable bowel syndrome (IBS), and overactive bladder medications. You may want to take this risk into account if you’re deciding whether to take these medications.

Antihistamine medications include: 

  • Diphenhydramine (Benadryl, Advil PM, Tylenol PM)
  • Chlorpheniramine (Chlor-tab, Aller-Chlor, Coricidin HBP)
  • Doxylamine (Unisom)

Tricyclic antidepressants include: 

  • Doxepin (Silenor) 
  • Nortriptyline (Pamelor) 
  • Amitriptyline (Elavil)

IBS medications include: 

  • Hyoscyamine (Levsin) 
  • Dicyclomine (Bentyl)

Overactive bladder medications include:

  • Darifenacin ER (Enablex)
  • Oxybutynin (Ditropan)
  • Tolterodine (Detrol, Detrol LA)
  • Trospium (Sanctura)
  • Solifenacin (Vesicare)
  • Fesoterodine (Toviaz)

2. Proton pump inhibitors

Studies suggest that men and women with dementia are more likely to be taking proton pump inhibitors (PPIs), 1.5 and 1.4 times, respectively. This doesn’t necessarily mean that PPIs directly cause dementia — only that there appears to be an association between the two. There are a couple of theories about how these medications could increase dementia risk:

  • PPIs have been shown to cause proteins, called β-amyloid plaques, to build up in the brains of mice. This is similar to the way someone’s brain changes with Alzheimer’s. 
  • Long-term use of PPIs could affect the absorption of vitamin B12, which could also increase your risk for dementia.

PPIs include:

  • Omeprazole (Prilosec)
  • Lansoprazole (Prevacid)
  • Esomeprazole (Nexium)
  • Pantoprazole (Protonix)

3. Pain medications

Many people are aware that the use of opioid pain medications can lead to dependence, overdose, and even death. But in addition to these concerns, studies show that people with heavy, long-term use of opioid medications have a slightly higher risk of getting dementia. Even people taking nonsteroidal anti-inflammatory drugs (NSAIDs) for pain had a high risk of developing dementia. 

It’s unclear whether the risk of dementia is related to taking pain medication or to the effects of chronic pain on the brain, or both. One newer study showed that older adults with chronic pain had a higher risk of developing dementia. This study didn’t measure how many of these adults were taking pain medications, so additional research is needed. 

Opioid medications include: 

  • Morphine
  • Hydrocodone (Norco)
  • Hydromorphone (Dilaudid)
  • Fentanyl (Duragesic)

NSAIDs include:

  • Naproxen (Aleve, Naprosyn)
  • Ibuprofen (Motrin, Advil)
  • Indomethacin (Indocin)

4. Benzodiazepines

Benzodiazepines (benzos) have been linked to dementia — especially in older adults. But not all research supports this link. 

Regardless, older adults should be cautious with these medications. Benzodiazepines can cause many other concerning side effects, including long-term dependence, breathing problems, confusion, drowsiness, problems with cognition, and even death. The risk for impaired brain functioning is increased with higher doses over an extended period of time.

Benzodiazepine medications include:

  • Lorazepam (Ativan)
  • Clonazepam (Klonopin)
  • Diazepam (Valium)
  • Alprazolam (Xanax, Niravam)

The bottom line

Many medications have been associated with an increased risk of dementia — especially if you take them for a long time. As with any medication, it’s important to weigh the pros and cons to figure out what’s best for you and your long-term health. 

If you rely on any of these medications to stay healthy, work with a healthcare professional to determine the lowest dose that will still treat your symptoms. This will decrease your risk of any associated side effects, including dementia.  

Dr. Nicole Rowe, MD, is a telehealth family practice physician. She received her medical degree from the University of North Carolina School of Medicine and completed her residency in family medicine atthe University of Colorado’s Swedish Medical Center.

Dementia drugs
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Editor
  • Website

Related Posts

Katsina unveils guidelines for state-funded family planning commodities

August 6, 2026

Kano suspends SMC malaria programme for probe

August 6, 2026

FG rallies support for Miss Nigeria at Miss World

August 6, 2026

Leave A Reply Cancel Reply

Abramowitz announces $500m solar financing for Nigerian universities

August 6, 2026

Katsina unveils guidelines for state-funded family planning commodities

August 6, 2026

FCTA to build more modern bus, taxi terminals in Abuja

August 6, 2026

Lagos launches access to market initiative for MSMEs

August 6, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.